News
Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient ...
Masimo (Nasdaq: MASI) announced today that it received FDA 510(k) clearance for expanded indications for its O3 regional ...
Masimo (MASI) announced the FDA 510(k) clearance of expanded indications for the delta hemoglobin parameters provided with O3 Regional Oximetry.
1d
Macworld on MSNThe Apple Watch sensor saga is over. Did everyone lose?
Apple, Masimo, and most importantly users all suffered from this bizarre legal wrangle. How did it get this far?
Medical technology company Masimo has been facing off with Apple in court since 2020, and while Masimo has scored some wins, ...
Apple will bring back the blood oxygen measurement feature to some of its watch models via a software update after receiving ...
The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...
StockStory.org on MSN13d
Masimo’s (NASDAQ:MASI) Q2: Beats On Revenue But Stock Drops
Medical tech company Masimo (NASDAQ:MASI) reported Q2 CY2025 results , with sales up 7.9% year on year to $370.9 million. The ...
The company said it would issue a software update to restart the technology, which was caught up in a patent dispute.
Blood oxygen tracking is returning to the Apple Watch after an 18-month hiatus, through a software update effective today. | ...
Apple to roll out redesigned Blood Oxygen feature for select U.S. Apple Watch models via software update, following a ...
Apple will bring a blood oxygen measurement feature to some of its watch models via a software update after receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results